Top Purchase Related
Home
>
Node
>
Subnode

Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection

Emery, S.; Cooper, D.A.

Australian and New Zealand Journal of Medicine 25(4): 344-349

1995

ISSN/ISBN: 0004-8291
PMID: 8540876
Document Number: 444126

Document emailed within 1 workday
Secure & encrypted payments

Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Stephens, J.R.; Rathbun, R.C.; Lockhart, S.M.; Bronze, M.S.; Greenfield, R.A. 2007: Part XV. Antiretroviral therapy for human immunodeficiency virus infection Journal of the Oklahoma State Medical Association 100(11): 417-424
Bearden, D.; Steenhoff, A.P.; Dlugos, D.J.; Kolson, D.; Mehta, P.; Kessler, S.; Lowenthal, E.; Monokwane, B.; Anabwani, G.; Bisson, G.P. 2015: Early antiretroviral therapy is protective against epilepsy in children with human immunodeficiency virus infection in botswana Journal of Acquired Immune Deficiency Syndromes 69(2): 193-199
Palacios, G.C.; Montalvo, M.S.; Fraire, M.I.; Leon, E.; Alvarez, M.T.; Solorzano, F. 2008: Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy International Journal of Pediatric Otorhinolaryngology 72(11): 1671-1681
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Marazzi, M.C.; Nielsen-Saines, K.; Buonomo, E.; Scarcella, P.; Germano, P.; Majid, N.A.; Zimba, I.; Ceffa, S.; Palombi, L. 2009: Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding Pediatric Infectious Disease Journal 28(6): 483-487
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Dormont, J.; Aboulker, J.P. 1994: Antiretroviral treatments in human immunodeficiency virus infection La Revue du Praticien 44(12): 1635-1642
Blum, L.; Bachmeyer, C. 1997: Antiretroviral treatment in human immunodeficiency virus infection Annales de Dermatologie et de Venereologie 124(9): 641-654
Frantz, J.M.; Murenzi, A. 2013: The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 10(3-4): 113-118
1991: Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection Disease Markers 9(6): 348
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Devare, S.G.; Desai, S.M.; Rupprecht, K.R.; Allen, R.G.; Dawson, G.J.; Hunt, J.C.; Casey, J.M. 1988: Genes of human immunodeficiency virus, type i (HIV-I), their expression in Escherichia coli, and their utility in diagnosis of virus infection Indian Journal of Biochemistry and Biophysics 25(6): 504-509
Caron, M.él.; Makuwa, M.; Souquière, S.; Descamps, D.; Brun-Vézinet, F.ço.; Kazanji, M. 2008: Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa Aids Research and Human Retroviruses 24(9): 1225-1228
Selimova, L.M.; Kalnina, L.B.; Serebrovskaya, L.V.; Ivanova, L.A.; Gulyaeva, A.N.; Nosik, D.N. 2016: Cytokines during the Human Immunodeficiency Virus Infection type 1(Hiv-1) Voprosy Virusologii 61(1): 39-41
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866